Skip to main content

Venrock — Portfolio, Page 6

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

153
Companies
$5.8B
Total invested
$47.6M
Avg. check
47
Industries
Biotechnology 12Health Care 9Medical 7Therapeutics 5Software 5Genetics 4+41 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 121–144 of 153
Kelonia Therapeutics
April 2022

Kelonia Therapeutics is developing a new wave of genetic medicines using its next-generation vivo gene delivery platform.

Biotechnology · Boston$50.0M Series A
Decodable
February 2022

Decodable is a serverless data integration and engineering platform for streaming data.

Developer Platform · San Francisco$20.0M Series A
Socrates.AI, Inc.
February 2022

Socrates AI brings deep expertise in Artificial Intelligence.

Artificial Intelligence (AI) · San FranciscoSeries A
Concentric Analgesics
January 2022

Concentric Analgesics is a biotechnology company that develops non-opioid therapeutics for the management of acute and chronic pain.

Biotechnology · San Francisco$20.0M Convertible Note
Mythic Therapeutics
December 2021

Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.

Biotechnology · Waltham$103.0M Series B
Ablaze Pharmaceuticals
November 2021

Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.

Biotechnology · Jingan$75.0M Series A
Stride Health
October 2021

Stride Health is a provider of an insurance recommendation platform designed to offer health insurance services.

Employee Benefits · San Francisco$47.0M Series C
Rebellion Defense
September 2021

Rebellion Defense's mission is to help the US and its partners outpace tomorrow's adversary.

Artificial Intelligence (AI) · Washington$150.0M Series B
Rarible
June 2021

Rarible is a community-centric NFT marketplace and infrastructure provider

Blockchain · Wilmington$14.2M Series A
percipient.ai
April 2021

Percipient.ai is a provider of an artificial intelligence advanced analytics platform designed to provide solutions for Intelligence.

Analytics · Santa Clara$50.0M Series C
Encoded Therapeutics
March 2021

Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.

Biotechnology · South San FranciscoSeries D
Cyteir Therapeutics
February 2021

Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.

Biopharma · Cambridge$80.0M Series C
Beckon
December 2020

Beckon provides data management and real-time marketing intelligence for better, faster decisions to grow your brand.

Analytics · San Mateo$290K Series Unknown
Federation Bio
October 2020

Federation Bio is a microbial therapeutics company targeting diseases in which the human microbiome can play a curative role.

Biotechnology · South San Francisco$50.0M Series A
PROPS
April 2020

PROPS creates a decentralized model for digital media that uses blockchain technology to reward the contributors that power the network.

Advertising · New York$2.0M Initial Coin Offering
Corvidia
March 2020

Corvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.

Biotechnology · Waltham$827K Convertible Note
10X Genomics
January 2020

10X Genomics ELV solutions and security systems company that provides an innovative genomics platform.

Biotechnology · PleasantonPost Ipo Equity
Attune Pharmaceuticals
January 2019

Attune Pharmaceuticals is a private biotechnology company.

Biotechnology · New York$23.0M Series B
Sojournix
January 2019

Sojournix is a biotechnology company developing innovative medicines for women's health and endocrine disorders.

Biotechnology · Arlington$44.0M Series C
Workframe
May 2018

The workflow optimization platform for commercial real estate professionals

Collaboration · New York$9.5M Series B
Hua Medicine
March 2018

Hua Medicine is a clinical-stage, innovative drug development company in China.

Biotechnology · ShanghaiSeries E
VeloCloud
March 2017

VeloCloud is a cloud networking services company that simplifies branch WAN networking.

Cloud Computing · Mountain View$35.0M Series D
Clara Lending
August 2016

Building the fastest, simplest way for consumers to finance their home.

Financial Services · San Francisco$19.3M Series A
Appthority
July 2016

Appthority is the global leader in enterprise mobile threat protection. We keep security teams informed, employees productive and enterpr

Mobile · San Francisco$7.0M Series B

Where Venrock invests

Biotechnology12
Health Care9
Medical7
Therapeutics5
Software5
Genetics4

About Venrock's portfolio

How many companies has Venrock invested in?▸

Venrock has invested in 153 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Venrock invest in?▸

Venrock's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Software. The firm invests across 47 different industry categories.

What is Venrock's largest investment?▸

Among tracked funding rounds, Rebellion Defense received $150.0M in a Series B round. Venrock's total known invested capital is $5.8B.

What is the average investment size for Venrock?▸

Venrock's average investment size is $47.6M across its portfolio of 153 companies.

What are Venrock's most recent investments?▸

Recent Venrock portfolio additions include Kelonia Therapeutics, Decodable, Socrates.AI, Inc., Concentric Analgesics, Mythic Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 153 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →